SAS code for 3-period, partial-replicated crossover study [RSABE / ABEL]

posted by scorp2011 – India, 2015-06-15 14:36 (3560 d 21:45 ago) – Posting: # 14957
Views: 8,189

We have two Test formulations (T1 and T2) and One single Reference formulation (R). We want to test for bioequivalence of each test formulation against the reference formulation i.e. T1 vs. R and T2 vs. R. The test drug is a candidate of "NTI" Please suggest me the whether we can analyze the study as per the SAS code (after adequately modifying the same) provided by the USFDA in Warfarin OGD guidance.
Regards
Sonu

Complete thread:

UA Flag
Activity
 Admin contact
23,408 posts in 4,920 threads, 1,665 registered users;
32 visitors (1 registered, 31 guests [including 10 identified bots]).
Forum time: 11:22 CET (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5